Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
Authors
Keywords
-
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-06
DOI
10.1186/s12935-019-1009-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction
- (2018) Rong Fan et al. DNA AND CELL BIOLOGY
- BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy
- (2018) Taylor C. Brown et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
- (2017) Chao Yang et al. Cell Death & Disease
- miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models
- (2017) Xuan Liu et al. Scientific Reports
- Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9
- (2016) Jianming Wang et al. Molecular Medicine Reports
- Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interaction Inhibitors
- (2016) John A. Wisniewski et al. ACS Medicinal Chemistry Letters
- BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
- (2016) XIAO-HUI LING et al. Oncology Letters
- BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer
- (2015) Andreas E. Moor et al. EBioMedicine
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
- (2013) Jiyeon Hyeon et al. Korean Journal of Pathology
- Multiple Functions of BCL-2 Family Proteins
- (2013) J. M. Hardwick et al. Cold Spring Harbor Perspectives in Biology
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-30c-2* Expressed in Ovarian Cancer Cells Suppresses Growth Factor-Induced Cellular Proliferation and Downregulates the Oncogene BCL9
- (2011) W. Jia et al. MOLECULAR CANCER RESEARCH
- Analysis of the Interaction of BCL9 with β-Catenin and Development of Fluorescence Polarization and Surface Plasmon Resonance Binding Assays for this Interaction
- (2009) Steven A. Kawamoto et al. BIOCHEMISTRY
- BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
- (2009) M. Mani et al. CANCER RESEARCH
- The PHD domain is required to link Drosophila Pygopus to Legless/β-catenin and not to histone H3
- (2009) Roman Kessler et al. MECHANISMS OF DEVELOPMENT
- β-Catenin hits chromatin: regulation of Wnt target gene activation
- (2009) Christian Mosimann et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A role of Pygopus as an anti-repressor in facilitating Wnt-dependent transcription
- (2008) J. Mieszczanek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now